atezolizumab
roche
['#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'imvigor,11', 'bladder']
important differentiator for these 2 adjuvant trials using ctdna: modern pts who are ctdna+ all get active treatment, imvigor011 1/3 of ctdna+ pts get placebo infusions for a year. equipoise for imv011 will be hard imo. we will wait for modern #bladdercancer #gu23 
Deputy Director @FoxChaseCancer. Professor GU Med Onc. @ASCO BOD 2020-24. Views mine. COI: https://t.co/fmmRpMCIWd